Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Quinn

Neurology

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neurology|October 1, 1990
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyJ Rivest, N Quinn, C D Marsden
Neurology|June 1, 1981
Bromocriptine and domperidone in the treatment of Parkinson diseaseN Quinn, A Illas, F Lhermitte, et al.
Neurology|September 1, 1984
Control of on/off phenomenon by continuous intravenous infusion of levodopaN Quinn, J D Parkes, C D Marsden
Neurology|July 9, 2003
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSPH R Morris, Y Osaki, J Holton, et al.
Neurology|April 14, 2004
Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson diseaseN L Khan, R Katzenschlager, H Watt, et al.
Neurology|November 29, 2002
Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?Y Osaki, G K Wenning, S E Daniel, et al.
Neurology|December 31, 1997
Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degenerationO Bandmann, M G Sweeney, S E Daniel, et al.
Neurology|July 13, 2006
Measuring quality of life in PSP: the PSP-QoLA Schrag, C Selai, N Quinn, et al.
Neurology|September 27, 2006
Severe tongue protrusion dystonia: clinical syndromes and possible treatmentS A Schneider, A Aggarwal, M Bhatt, et al.
Neurology|January 12, 2005
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutationN L Khan, C Scherfler, E Graham, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neurology|October 1, 1990
Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyJ Rivest, N Quinn, C D Marsden
Neurology|June 1, 1981
Bromocriptine and domperidone in the treatment of Parkinson diseaseN Quinn, A Illas, F Lhermitte, et al.
Neurology|September 1, 1984
Control of on/off phenomenon by continuous intravenous infusion of levodopaN Quinn, J D Parkes, C D Marsden
Neurology|July 9, 2003
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSPH R Morris, Y Osaki, J Holton, et al.
Neurology|April 14, 2004
Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson diseaseN L Khan, R Katzenschlager, H Watt, et al.
Neurology|November 29, 2002
Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?Y Osaki, G K Wenning, S E Daniel, et al.
Neurology|December 31, 1997
Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degenerationO Bandmann, M G Sweeney, S E Daniel, et al.
Neurology|July 13, 2006
Measuring quality of life in PSP: the PSP-QoLA Schrag, C Selai, N Quinn, et al.
Neurology|September 27, 2006
Severe tongue protrusion dystonia: clinical syndromes and possible treatmentS A Schneider, A Aggarwal, M Bhatt, et al.
Neurology|January 12, 2005
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutationN L Khan, C Scherfler, E Graham, et al.
Pageof 2